-+ 0.00%
-+ 0.00%
-+ 0.00%

Adaptive Biotechnologies director Michelle Renee Griffin disposes of 52,084 common shares worth $1,051,855.12

PUBT·06/29/2026 23:50:21
Listen to the news
Adaptive Biotechnologies director Michelle Renee Griffin disposes of 52,084 common shares worth $1,051,855.12
  • Adaptive Biotechnologies director Michelle Renee Griffin sold 52,084 common shares on June 25, 2026 at USD 20.18.
  • Sale followed the exercise of 52,084 stock options at USD 7.8 on the same day.
  • Directly held common shares fell to 15,625.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Adaptive Biotechnologies Corporation published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001229765-26-000008), on June 29, 2026, and is solely responsible for the information contained therein.